In The News

Latest News

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

Ofirnoflast ASH 2025 Presentations

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Mar 11, 2025

Halia Therapeutics Awarded Novo Nordisk Golden Ticket to Advance Obesity and Inflammation Research

Halia Tx awarded Novo Nordisk Golden Ticket

Read more